Hyponatremia is a risk factor of hepatic encephalopathy in patients with cirrhosis: a prospective study with time-dependent analysis.
about
Clinical manifestations of portal hypertensionDo vasopressin V2 receptor antagonists benefit cirrhotics with refractory ascites?Current pathogenetic aspects of hepatic encephalopathy and noncirrhotic hyperammonemic encephalopathyHyponatremia in cirrhosis: pathophysiology and managementHyperammonemia and systemic inflammatory response syndrome predicts presence of hepatic encephalopathy in dogs with congenital portosystemic shuntsHepatic Encephalopathy: From the Pathogenesis to the New Treatments.Brain magnetic resonance spectroscopy in episodic hepatic encephalopathy.Hepatic encephalopathy in acute-on-chronic liver failure.Hepatocellular carcinoma treated by conventional transarterial chemoembolization in field-practice: serum sodium predicts survival.Effect of the pretransplant serum sodium concentration on outcomes following liver transplantation.A capillary blood ammonia bedside test following glutamine load to improve the diagnosis of hepatic encephalopathy in cirrhosis.The clinical course of alcoholic cirrhosis: effects of hepatic metabolic capacity, alcohol consumption, and hyponatremia--a historical cohort study.Profile of hepatic encephalopathy in children with cirrhosis and response to lactulose.Hyponatremia in hepatocellular carcinoma complicating with cirrhosis.Pathogenesis of hepatic encephalopathy: role of ammonia and systemic inflammation.Hyponatremia: A Risk Factor for Early Overt Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt CreationPresence of Systemic Inflammatory Response Syndrome Predicts a Poor Clinical Outcome in Dogs with a Primary Hepatitis.Oxidative stress markers in the brain of patients with cirrhosis and hepatic encephalopathyHyponatremia in cirrhosis and end-stage liver disease: treatment with the vasopressin V₂-receptor antagonist tolvaptan.Cognitive performance as a predictor of hepatic encephalopathy in pretransplant patients with cirrhosis receiving psychoactive medications: a prospective studyHyponatremia and Hepatorenal SyndromeDifferential impact of hyponatremia and hepatic encephalopathy on health-related quality of life and brain metabolite abnormalities in cirrhosis.Impact of pretransplant hepatic encephalopathy on liver posttransplantation outcomes.Clinical management of hepatic encephalopathy.Meta-analysis: the safety and efficacy of vaptans (tolvaptan, satavaptan and lixivaptan) in cirrhosis with ascites or hyponatraemia.Systemic inflammation and ammonia in hepatic encephalopathy.Satavaptan treatment for ascites in patients with cirrhosis: a meta-analysis of effect on hepatic encephalopathy development.The nutritional management of hepatic encephalopathy in patients with cirrhosis: International Society for Hepatic Encephalopathy and Nitrogen Metabolism Consensus.Update on management of patients with overt hepatic encephalopathy.Hepatic encephalopathy: early diagnosis in pediatric patients with cirrhosisKidney injury in cirrhosis: pathophysiological and therapeutic aspects of hepatorenal syndromes.Low-dose tolvaptan for the treatment of dilutional hyponatremia in cirrhosis: a case report and literature review.Pathophysiology and management of hepatic encephalopathy 2014 update: Ammonia toxicity and hyponatremia.Hyponatremia in Patients with Cirrhosis of the Liver.Sodium benzoate for treatment of hepatic encephalopathy.The Changing Role of Sodium Management in Cirrhosis.Prevention of the Osmotic Demyelination Syndrome After Liver Transplantation: A Multidisciplinary Perspective.Electrolyte and Acid-Base Disturbances in End-Stage Liver Disease: A Physiopathological Approach.Ascites, refractory ascites and hyponatremia in cirrhosis.Management of ascites and hepatorenal syndrome.
P2860
Q24633762-A9FE8EB0-749B-487A-9013-51260096FA90Q26778032-CCD1684D-EA40-49A3-A67A-ED8FC98745AFQ27003171-BE45E8E3-A27C-4122-8657-3CF13A1B7784Q27027861-FE262DEE-0D79-48F1-A0A5-2EEDE3140421Q28538254-8B5DA95F-CCF6-4893-8189-667372AA9F8FQ30381016-4DB94459-64A3-428C-8FB0-AE5912AEDFB4Q30578055-ECB93493-030F-4C64-81F8-AE6D220C1CF3Q30959584-13EACEF2-8714-46C3-BB58-E5DE18B8FCC2Q33845513-0929312B-C866-4AD2-9634-A9ACAF1F521EQ34028161-C063E33F-B8E9-4285-9742-0B69027F2016Q34094175-0B6D6C03-E7D8-48B8-B52B-92867894B755Q34417619-9B15E8ED-C013-4ADD-8D04-FDCE33F9ECDFQ34996031-B3908EB0-4FE0-478B-A274-5551A9AAC035Q35349239-5D091ED1-0763-4F99-A970-BA48CED5D11DQ35642846-1132ECCC-6325-4141-8CB6-9CE0F305B376Q35667270-54ADE8D9-C57A-4490-84F9-8B17FDCAB259Q35903848-05A144D0-2583-4891-A0B7-53F0302A6923Q36091445-0BEF52F7-BD95-4169-B7EA-FBE8C3F95E56Q36319648-C2AA0DAC-2A52-4950-97FE-0EC559EB3303Q36706010-2E4336D9-A0E6-409A-BCDD-47665BC2E6C4Q36812531-1BD7EB7C-3582-4D27-B689-06D3CB706E0AQ37107261-E580C2D6-71B6-44A0-9656-344A275A01C8Q37353473-EDF4F1E3-7902-437D-926A-DEA1AE1B128BQ37735853-D470AC96-1BF9-41DB-8B43-92269A483E65Q38036326-3AAE9C75-FD67-4D9E-AFEB-09B7F0A383C4Q38065978-33154000-A64C-470E-9272-A66E9658624EQ38086800-C976557B-8E7F-46F3-B21A-09ED0C206958Q38087547-28A93AFA-3CCB-4013-B488-A6C59F068FADQ38129187-0461606F-1E3C-456C-9E49-0149842B6FEAQ38199095-74A8B422-A69E-4559-8FCC-B4C35844D446Q38199770-E23C0F55-7E7F-4A24-8B79-290F207BAC57Q38266482-4648EB6E-E5B1-47F6-8B2D-C35BC3BDF14FQ38325703-DE2E9028-AE2D-4E02-9610-17944A484397Q38559606-5BB8140F-CAA3-42C5-AB19-C171FC819F20Q38633241-24174E7E-246E-4D1B-A9FC-7D645EF7945CQ38796241-45243973-4313-4BD6-826B-F27A121B1829Q39250455-037A8823-2F3B-4294-AA6E-A44C4B70BD90Q39304722-FDB11F58-E91D-4C8B-8208-4D5E8A69DB7AQ39323841-D492DD3A-8885-4665-A8E4-DED77A862801Q40081708-E731DF85-B5DD-4B5D-B71B-2045BA2DEC2B
P2860
Hyponatremia is a risk factor of hepatic encephalopathy in patients with cirrhosis: a prospective study with time-dependent analysis.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Hyponatremia is a risk factor ...... with time-dependent analysis.
@en
Hyponatremia is a risk factor ...... with time-dependent analysis.
@nl
type
label
Hyponatremia is a risk factor ...... with time-dependent analysis.
@en
Hyponatremia is a risk factor ...... with time-dependent analysis.
@nl
prefLabel
Hyponatremia is a risk factor ...... with time-dependent analysis.
@en
Hyponatremia is a risk factor ...... with time-dependent analysis.
@nl
P2093
P2860
P50
P921
P356
P1476
Hyponatremia is a risk factor ...... y with time-dependent analysis
@en
P2093
Aldo Torre
Beatriz Gómez-Ansón
Lorena Rami
M E Baccaro
Marta Martín-Llahí
Mónica Guevara
P2860
P304
P356
10.1038/AJG.2009.293
P407
P577
2009-06-01T00:00:00Z